Comparison of Colistin Susceptibility <em>via</em> Two Different Methods in Gram-Negative Extensive Drug-Resistance Isolates from ICU Patients

J Coll Physicians Surg Pak. 2024 Jun;34(6):677-681. doi: 10.29271/jcpsp.2024.06.677.

Abstract

Objective: To compare the susceptibility of colistin by two methods in extensive drug-resistant (XDR) Gram-negative isolates from ICU patients.

Study design: Cross-sectional comparative analysis. Place and Duration of the Study: Department of Microbiology, Combined Military Hospital Karachi, Pakistan, from August 2022 to February 2023.

Methodology: A total of 100 clinical specimens received from the intensive care unit yielded growth of extensively drug-resistant gram-negative bacteria, which were evaluated for polymyxin E susceptibility. The agar dilution method was compared with the reference broth microdilution (BMD) method. Minimum inhibitory concentration (MIC) was noted for both methods.

Results: Comparison of the MIC method by agar dilution showed a 90% correlation with the reference method of broth microdilution. With MICs within the acceptable range of the clinical and laboratory standards institute (CLSI) recommendations, 89 isolates were susceptible to colistin, whereas only 11 remained resistant. Polymyxin E's MIC 50 and MIC 90 were determined to be 1 and 2 µg/ml, respectively, with 97% susceptibility.

Conclusion: Agar dilution susceptibility method can be used for screening purposes for the susceptibility testing of polymyxin E. This method is reliable and can easily identify the heteroresistance.

Key words: Extensively drug-resistant, Broth microdilution, Multidrug-resistant, Agar dilution, Minimum inhibitory concentration, Colony forming unit.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Colistin* / pharmacology
  • Cross-Sectional Studies
  • Drug Resistance, Multiple, Bacterial*
  • Gram-Negative Bacteria* / drug effects
  • Gram-Negative Bacteria* / isolation & purification
  • Gram-Negative Bacterial Infections* / drug therapy
  • Gram-Negative Bacterial Infections* / microbiology
  • Humans
  • Intensive Care Units*
  • Microbial Sensitivity Tests* / methods
  • Pakistan

Substances

  • Colistin
  • Anti-Bacterial Agents